Greetings to all our valuable shareholders.
As
you all know the vision statement of Govt. of India on Biotechnology
is :
“Attaining new heights
in
biotechnology research,
shaping
biotechnology
into a
premier precision tool
of the future
for creation
of wealth
and ensuring
social
justice -
specially for
the
welfare of
the poor.”
We at “Genomic Valley Biotech Ltd” are also trying to adhere to the
same and putting our efforts to realize the goals and objectives of
the same.
Indian biotechnology sector has excellent potential and is expected
to touch five billion-dollar mark by the end of this year - 2010," a
report jointly prepared by industry chamber CII and consultancy firm
KPMG said.
"India
is ranked among the top 12 biotech destinations in the world and is
the third biggest in Asia-Pacific in terms of the number of biotech
companies," it added. Investments in the segment are also growing
at the rate of about 38 per cent for the last few years and have
touched 560 million dollars in 2006-07. Biopharma is one of the
important segments of the Indian biotechnology sector and it
constitutes about 70 per cent of the domestic biotech industry. Of
the total 325 biotechnology companies in
India
,
more than 40 per cent are in the biopharma sector, the report said.
As you know Genomic Valley Biotech Ltd (GVBL)., erstwhile M/S Tushar
Agribusiness Consortium India Ltd., was formed with the objective of
conducting research in the field of Biotechnology (Plant & Animal)
and also to undertake commercial production of Plant Tissue Cultured
Plants of different species to feed the genetically improved plant
market nationally as well as internationally.
GVBL is having
an unique combination of activities to contribute towards its
Revenue Model. The activities are as follows :
-
Creation of Brain Pool
-
Training Institute
-
Commercial Production Unit
-
Ultramodern Research &
Development Facility
-
International
Collaboration for R&D Projects
Brain Pool & Training Institute
In any growing field, the requirements of quality man power grows
exponentially. And only good quality man power can give the quality
output for the progress of the field.
The company successfully contacted ten scientists in the field of
Biotechnology from some premiere institutes in
India
and formed a Team of Scientists to extending support and guidance
for the company’s future activities
Our company is having a focused vision to establish a Biotechnology
Training Institute in the state of Haryana. With a balanced study
and research facilities, the Institute will create “Fresh Brain Pool
in Biotechnology” in terms of it’s students and scholars. This
scholarly strength will be utilized in-house for our upcoming
Commercial Plant Tissue Culture Unit in the near future, and also
this Brain Pool will cater to the need of the country for talented
man power in the field of Biotechnology.
Commercial Plant Tissue Culture Production Unit
The commercial potential of plant-cell tissue culture has not yet
been fully recognized and is underexploited. Plant-cell tissue
culture has two primary products: plant tissue for efficient
micropropagation of plants and the use of plant-tissue culture to
produce specialty chemicals.
Plant-cell, tissue, and organ cultures can be used in processes
analogous to traditional fermentation processes for producing
chemicals. Although less than 5% of the world's plants have even
been identified taxonomically, from among the known plants over
20,000 chemicals are produced - about 4 times as many as from all
microorganisms. Very few of the chemicals in pure or semi pure form
have been tested for their pharmacological activity for other uses.
The enzymatic systems in plants can be used to generate completely
new compounds when supplied with analogues of natural substrates;
thus, plants contain an underused biochemical diversity. Even the
limited use of this vast biochemical potential has had important
impacts on mankind; in western countries, about one-fourth of all
medicines are derived from compounds extracted from plants. Other
plant products are used as flavors, fragrances, or pesticides.
Alongside,
company is planning to set up Plant Tissue Culture unit to cater to
the tissue cultured plants market nationally and internationally.
Also the company is having plan to enter into the field of
producing bio compounds from plants using plant tissue culture
techniques.
International Collaboration in Biotechnology Research & Development
GVBL, is also having concrete plan to set up Ultramodern research
and Development facility where biotechnology research of
international standard can be conducted. Communication is on with
the research labs of different countries for getting into
collaboration for different research programs in plant as well as
animal biotechnology.
Thus with a wide vision as above, our company “Genomic Valley
Biotech Ltd” is rightly poised to having it’s breakthrough in the
field of biotechnology. We are looking forward to you to have your
support for enabling us to achieve our goals.
Yogesh
Agrawal
Chairman & Managing Director
Genomic Valley biotech Ltd.
|